Bluebird Bio (BLUE) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -553.6 | -556.9 | -215.6 | -167.2 | -156.8 | -115.8 | ||
| Changes by years, y/y, % | -28% | +1% | -61% | -22% | -6% | -27.3% | |||
Bluebird Bio. EBITDA US GAAP, bln rub
Bluebird Bio. EBITDA US GAAP, changes, %
Bluebird Bio. EBITDA US GAAP, sum by quarters, bln rub
Bluebird Bio (BLUE) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -68.0 | -59.4 | -39.7 | -9.00 | -7.68 | -115.8 | |
| Changes by years, y/y, % | -355% | +2% | -55% | -87% | ||||
| Changes by quarters, q/q, % | +37% | -13% | -33% | -77% | -15% | |||